Skip to main content

E-book

Revolutionizing specialty drug management

Get an in-depth assessment of the ways Specialty Fusion™ is revolutionizing specialty drug management. 

A cross-benefit drug management solution

Explore the work being done with Optum® Specialty Fusion and how it’s reshaping the healthcare industry. In a collection of articles, this e-book:

  • Delves into the intricate web of specialty drug management
  • Reveals how Specialty Fusion simplifies the prior authorization process
  • Uncovers the potential cost savings and improved patient outcomes this solution offers

Related healthcare insights

Article

Second Opinion plus COEs can help address avoidable MSK surgeries 

Musculoskeletal surgeries are driving up costs. Payers can bend the curve with digital care, expert second opinions and high-performing surgical centers.

Article

How Second Opinions help deliver first-rate outcomes

Virtual second opinions give members a checkpoint before major treatment decisions. Labor and trust funds get better outcomes and smarter spend.

White paper

Drive improved outcomes and lower costs for blood cancers with CAR T therapy

This white paper analyzes CAR T utilization, outcomes and economic impact across commercial and Medicare populations in the Optum Cell and Gene Therapy (CGT) program from 2022–2024.